Allan Goldstein - Regenerx Biopharm Chairman
| RGRXDelisted Stock | USD 0.03 0.01 25.00% |
Chairman
Dr. Allan L. Goldstein Ph.D. is Chairman of the Board, Founder, Chief Scientific Officer of the Company. Dr. Goldstein is Emeritus Professor former Chairman of the Department of Biochemistry and Molecular Medicine at the George Washington University School of Medicine and Health Sciences. Dr. Goldstein is a recognized expert in the field of immunology and protein chemistry, having authored over 435 scientific articles in professional journals. He is also the inventor on over 25 issued andor pending patents in biochemistry, immunology, cardiology, cancer and wound healing. Dr. Goldstein discovered several important compounds, including Ta1, which is marketed worldwide, and Tb4, which is the basis for RegeneRxs clinical program. Dr. Goldstein served on the Board of Trustees of the Sabin Vaccine Institute from 2000 to 2012 and on the Board of Directors of the Richard B. and Lynne V. Cheney Cardiovascular Institute from 2006 to 2012 since 1982.
| Age | 85 |
| Tenure | 42 years |
| Phone | 301 208 9191 |
| Web | https://www.regenerx.com |
Regenerx Biopharm Management Efficiency
The company has return on total asset (ROA) of (0.8397) % which means that it has lost $0.8397 on every $100 spent on assets. This is way below average. Regenerx Biopharm's management efficiency ratios could be used to measure how well Regenerx Biopharm manages its routine affairs as well as how well it operates its assets and liabilities.Regenerx Biopharm In currently holds 1.14 M in liabilities. Regenerx Biopharm has a current ratio of 1.03, suggesting that it may have difficulties to pay its financial obligations when due. Debt can assist Regenerx Biopharm until it has trouble settling it off, either with new capital or with free cash flow. So, Regenerx Biopharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Regenerx Biopharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Regenerx to invest in growth at high rates of return. When we think about Regenerx Biopharm's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Lindsay Rosenwald | Fortress Biotech Pref | 68 | |
| Eric Weisblum | Silo Pharma | 54 | |
Management Performance
| Return On Asset | -0.84 |
Regenerx Biopharm Management Team
Elected by the shareholders, the Regenerx Biopharm's board of directors comprises two types of representatives: Regenerx Biopharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Regenerx. The board's role is to monitor Regenerx Biopharm's management team and ensure that shareholders' interests are well served. Regenerx Biopharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Regenerx Biopharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Finkelstein, CEO and President and Director | ||
| Nabila Turjman, Ex Affairs | ||
| Allan Goldstein, Founder, Chairman, Chief Scientific Advisor and Chairman of Medical and Scientific Advisory Board |
Regenerx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Regenerx Biopharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.84 | ||||
| Operating Margin | (19.03) % | ||||
| Current Valuation | 22.91 M | ||||
| Shares Outstanding | 143.55 M | ||||
| Shares Owned By Insiders | 45.99 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 19.19 K | ||||
| Price To Earning | 17.73 X | ||||
| Price To Sales | 261.81 X | ||||
| Revenue | 76.76 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Regenerx OTC Stock
If you are still planning to invest in Regenerx Biopharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regenerx Biopharm's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |